EUVIMEDEUVIMED entdecken
Crossref

Porous Fe/Cu Nanoreactor with Dual Insurance Design for Precision Chemotherapy and Chemodynamic Therapy

Xianyu Zhu iD, Lingli Gao, Yanbo Zheng, Peng Fei Zhao, Hanrui Wei, Ruixue Liu, Liping Zhao, Junyi Zhang, Qi Sun, Lingling Zheng, Han Lv, JiGang Yang und 2 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202405229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Xianyu Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Precision and Intelligence Medical Imaging Lab, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Rd., Xicheng Dist., Beijing, 1000…. Hauptthemen laut MEDLINE: Copper, Iron, Antineoplastic Agents, Metal Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, CAMS Innovation Fund for Medical Sciences, Beijing Friendship Hospital, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor prognosis and chemotherapy response stem from difficulties in precise targeting and the lack of effective synergistic treatments. Nanozymes show promising potential in tumor chemodynamic therapy (CDT) by catalyzing hydrogen peroxide (H₂O₂) decomposition and glutathione depletion in the tumor microenvironment (TME). However, integrating precise chemotherapy targeting with CDT remains challenging. In this study, a porous Fe/Cu bimetallic nanozyme carrier (FeCuNPs) is developed for co‐loading with the humanized 3F8 anti‐GD2 disialoganglioside antibody (3F8) and the novel pyridazinone‐based chemotherapeutic agent (IMB), forming a nanoreactor (3F8@FeCuNPs@IMB) for targeted chemotherapy and CDT. The nanoreactor responds specifically to the acidic TME as a primary insurance, allowing for the controlled release of IMB at the tumor site. The targeting antibody 3F8 coating on the surface of the nanozyme carrier acts as a secondary insurance, minimizing chemotherapy drug leakage during the delivery process and ensuring precise targeting for effective chemotherapy. Furthermore, FeCuNPs act as peroxidase‐like (POD) and glutathione oxidase‐like (GSHOX) enzymes, catalyzing hydroxyl radical (•OH) generation and depleting excess GSH, enhancing CDT. The results in vitro and in vivo indicate that the dual insurance designed 3F8@FeCuNPs@IMB offers a promising prospect for a targeted, precise, and effective combination of chemotherapy and CDT against melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperIronAntineoplastic AgentsMetal NanoparticlesAnimalsHumansMiceCell Line, TumorPorosityTumor MicroenvironmentGlutathionePrecision MedicineDrug Carriers

Stichwörter der Autor:innen

chemodynamic therapychemotherapydual insuranceporous nanozymetargeted therapy

Substanzen

CopperIronAntineoplastic AgentsGlutathioneDrug Carriers

Autor:innen und Institutionen

  • Precision and Intelligence Medical Imaging Lab, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Rd., Xicheng Dist., Beijing, 100050, China.
  • Beijing Clinical Research Institute, 95 Yong'an Rd., Xicheng Dist., Beijing, 100050, China.
  • Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Tiantan Xili No. 1, Beijing, 100050, China.

ORCID-Profile: Xianyu Zhu

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • CAMS Innovation Fund for Medical Sciences
  • Beijing Friendship Hospital, Capital Medical University

Zitieren

APA

Zhu, X., Gao, L., Zheng, Y., Zhao, P. F., Wei, H., Liu, R., Zhao, L., Zhang, J., Sun, Q., Zheng, L., Lv, H., Yang, J., Gong, J., & Wang, Z. (2025). Porous Fe/Cu Nanoreactor with Dual Insurance Design for Precision Chemotherapy and Chemodynamic Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405229

Vancouver

Zhu X, Gao L, Zheng Y, Zhao PF, Wei H, Liu R, et al. Porous Fe/Cu Nanoreactor with Dual Insurance Design for Precision Chemotherapy and Chemodynamic Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405229

BibTeX
@article{Zhu2025,
  author = {Zhu, Xianyu and Gao, Lingli and Zheng, Yanbo and Zhao, Peng Fei and Wei, Hanrui and Liu, Ruixue and Zhao, Liping and Zhang, Junyi and Sun, Qi and Zheng, Lingling and Lv, Han and Yang, JiGang and Gong, Jianhua and Wang, Zhenchang},
  title = {Porous Fe/Cu Nanoreactor with Dual Insurance Design for Precision Chemotherapy and Chemodynamic Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202405229}
}
Kostenlos starten →